ALMGDA
UTHR icon

AG2R La Mondiale Gestion d'Actifs’s United Therapeutics UTHR Stock Holding History

AG2R La Mondiale Gestion d'Actifs’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Buy
+2,393
New +$1.35M 0.05% 323

Other funds holding UTHR

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

AG2R La Mondiale Gestion d'Actifs's UTHR Position: Q2 2026 in Review

AG2R La Mondiale Gestion d'Actifs opened a new position in United Therapeutics (UTHR) in Q2 2026: 2,393 shares worth $1.3M. The stake represents 0.05% of the portfolio and ranks #323 among its holdings.

172 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • AG2R La Mondiale Gestion d'Actifs held 2,393 shares of United Therapeutics worth $1.3M as of Q2 2026.
  • United Therapeutics was a new AG2R La Mondiale Gestion d'Actifs position in Q2 2026.
  • United Therapeutics made up 0.05% of AG2R La Mondiale Gestion d'Actifs's portfolio in Q2 2026, its #323 holding.
  • 172 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on AG2R La Mondiale Gestion d'Actifs's 13F filing for Q2 2026, filed 23 Jul 2026.